[2] Novartis. Retrieved Mar 26, 2021，from https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-study-evaluating-canakinumab-acz885-second-or-third-line-treatment-combination-chemotherapy-non-small-cell-lung-cancer
[3] Biom Therapeutics. Retrieved Mar 26, 2021，from https://biomtherapeutics.com/pipeline/
*声明：本文由入驻新浪医药新闻作者撰写，观点仅代表作者本人，不代表新浪医药新闻立场。▽关注【药明康德】微信公众号
美业风向朝哪吹？或许这
